Companies
ARK Investment Management
the ARK Genomic Revolution ETF (ARKG) is an actively managed thematic fund concentrated in genomics and biotechnology companies, also offered through a European UCITS structure for cross-border distribution.
- Country
- United States
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| finance-investment | ✓ | ✓ | ✓ |
Regulatorsftcreach
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioeconomy as institutional asset class | finance-investment | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.